527
Views
4
CrossRef citations to date
0
Altmetric
Review

Proteomics advances for precision therapy in ovarian cancer

, , , , , & show all
Pages 841-850 | Received 25 Jul 2019, Accepted 06 Sep 2019, Published online: 13 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ann M. Cathcart, Hannah Smith, Marilyne Labrie & Gordon B. Mills. (2022) Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies. Expert Review of Proteomics 19:2, pages 115-129.
Read now

Articles from other publishers (3)

Liujia Qian, Rui Sun, Zhangzhi Xue & Tiannan Guo. (2023) Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective. Molecular & Cellular Proteomics 22:7, pages 100578.
Crossref
Aruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, Anita Bolina, Michele Moschetta, Elie Rassy & Stergios Boussios. (2022) Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. Proteomes 10:2, pages 16.
Crossref
Annie H. Ren, Eleftherios P. Diamandis & Vathany Kulasingam. (2021) Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification. Molecular & Cellular Proteomics 20, pages 100155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.